stoxline Quote Chart Rank Option Currency Glossary
  
(CRBD)
  0 (0%)    06-16 19:42
Open:
High:
Volume: 0
  
Pre. Close:
Low:
Market Cap: 0(M)
Technical analysis
2026-06-16 4:40:43 PM
Short term     
Mid term     
Targets 6-month :  27 1-year :  27.7
Resists First :  23.11 Second :  23.72
Pivot price 22.52
Supports First :  22.13 Second :  18.42
MAs MA(5) :  22.46 MA(20) :  22.56
MA(100) :  23.01 MA(250) :  22.93
MACD MACD :  -0.2 Signal :  -0.2
%K %D K(14,3) :  51 D(3) :  39.1
RSI RSI(14): 47.3
52-week High :  24.08 Low :  21.06
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ CRBD ] has closed below upper band by 36.5%. Bollinger Bands are 41.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 22.7 - 22.82 22.82 - 22.91
Low: 22.28 - 22.4 22.4 - 22.49
Close: 22.42 - 22.62 22.62 - 22.78
Company Description

Headline News

Mon, 15 Jun 2026
CRBD Gains 1.1% as Bond Price Approaches Resistance, Supported by Improving Credit Sentiment - Fast Moving Stocks - newsline.com

Thu, 11 Jun 2026
Corebridge Financial, Inc. - Corporate bond (CRBD) price target decreased by 13.14% to 30.59 - MSN

Thu, 11 Jun 2026
Liquidity Mapping Around (CRBD) Price Events - Stock Traders Daily

Sun, 31 May 2026
Why (CRBD) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Tue, 06 Jan 2026
Optimizing butorphanol-dexmedetomidine dosing for managing catheter-related bladder discomfort post-anesthesia: a randomized trial | Scientific Reports - Nature

Sat, 20 Dec 2025
Tibial Nerve Stimulation Lowers Catheter-Related Bladder Discomfort After Surgery - EMJ

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
Sector:
Industry:
Shares Out 0 (M)
Shares Float 0 (M)
Held by Insiders 0 (%)
Held by Institutions 0 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS 0
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) 0 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android